AMYLOBAN
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Feb 2009)
What this means for you
This application is over — abandoned 13 Feb 2009. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77210170
- Mark type
- Stylized text
- Filed
- 19 Jun 2007
- Published for opposition
- 20 May 2008
- Abandoned
- 13 Feb 2009
- Attorney of record
- Stephen M. O'Neill
Goods and services
- Class 001 — Chemicals: preparations and extracts made from mushrooms for use in the manufacture of dietary, nutritional and food supplements and pharmaceutical products
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of neurodegenerative and cognitive disorders, Alzheimer's disease, Parkinson's disease, ADHD (attention-deficit hyperactivity disorder) or ADS (attention deficit syndrome), memory loss, depression and related neurological diseases or conditions made from mushrooms or mushroom extracts
Owner
- Maitake Products, Inc., East Rutherford, NJ, US
- Maitake Products, Inc., East Rutherford, NJ, US
Prosecution history
- 22 Apr 2009 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 22 Apr 2009 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Mar 2009 — DIVISIONAL PROCESSING COMPLETE
- 11 Feb 2009 — DIVISIONAL REQUEST RECEIVED
- 18 Mar 2009 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Feb 2009 — FAX RECEIVED
- 11 Feb 2009 — TEAS REQUEST TO DIVIDE RECEIVED
- 11 Feb 2009 — TEAS STATEMENT OF USE RECEIVED
- 11 Feb 2009 — FAX RECEIVED
- 11 Feb 2009 — FAX RECEIVED
- 11 Feb 2009 — FAX RECEIVED
- 12 Aug 2008 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 20 May 2008 — PUBLISHED FOR OPPOSITION
- 30 Apr 2008 — NOTICE OF PUBLICATION
- 14 Apr 2008 — LAW OFFICE PUBLICATION REVIEW COMPLETED